Skip to main content
Log in

Transcription factor AP-2β genotype, striatal dopamine D2 receptor density and cerebrospinal fluid monoamine metabolite concentrations in humans

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary.

Transcription factor AP-2β has been suggested to influence brain monoaminergic systems by regulating target genes. In order to explore a possible functional role, AP-2β genotype was analysed in relation to striatal dopamine D2 receptor density determined in vivo by positron emission tomography in human subjects (n = 52). The AP-2β genotype was also analysed in relation to cerebrospinal fluid (CSF) concentrations of homovanillic acid (HVA), 3-methoxy-4-hydroxy-phenylglycol (MHPG) and 5-hydroxyindoleacetic acid (5-HIAA) in healthy human subjects (n = 90). There was no association between the AP-2β genotype and measures of dopamine receptor density, or CSF 5-HIAA concentrations. However, AP-2β genotype was associated with CSF-levels of HVA (in women) and MHPG. These data may suggest a functional involvement of AP-2β in the dopaminergic system, but should be interpreted with caution until replicated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Damberg, M., Berggård, C., Farde, L. et al. Transcription factor AP-2β genotype, striatal dopamine D2 receptor density and cerebrospinal fluid monoamine metabolite concentrations in humans. J Neural Transm 111, 537–545 (2004). https://doi.org/10.1007/s00702-003-0097-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-003-0097-4

Navigation